https://www.selleckchem.com/pr....oducts/pexidartinib-
001). Finally, chemotherapy was significantly associated with OS in patients with differentiation grades II-IV (P=0.004) and patients with adenocarcinoma (P=0.005). This nomogram provides a convenient and reliable tool for individual evaluations and clinical decision-making for patients with stage IB NSCLC; among these patients, those with differentiation grades II-IV or adenocarcinoma could benefit from chemotherapy. This nomogram provides a convenient and reliable tool for individual evaluations and clinical decision-maki